INBIOGEN Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 741.51 million compared to KRW 776.19 million a year ago. Net income was KRW 8,610.13 million compared to KRW 14,381.25 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,340 KRW | -2.30% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 67.31M | |
+12.46% | 41.49B | |
+25.13% | 18.2B | |
-15.17% | 7.22B | |
+12.68% | 5.34B | |
-10.31% | 3.71B | |
-28.62% | 2.73B | |
-11.49% | 2.57B | |
+19.16% | 2.03B | |
-16.13% | 1.58B |
- Stock Market
- Equities
- A101140 Stock
- News INBIOGEN Co., Ltd.
- INBIOGEN Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024